prostaglandin E2

Diabetes, cardiovascular drug targets

Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

gloved hand placing test tube on rack full of other test tubes

Searching out pancreatic cancer risk

Vanderbilt researchers have identified a biomarker that could be used to predict pancreatic cancer risk.